Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
agilon health Inc(AGL)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AGL
09/15/2026: AGL (2-star) is currently NOT-A-BUY. Pass it for now.
agilon health is a healthcare services company that provides a platform for community-based physicians to participate in value-based care models, primarily for Medicare Advantage patients. The company has a leading position in supporting independent practices through technology and data analytics, which is a key growth area in the US healthcare landscape. Its primary investment story hinges on the broader market shift toward cost-effective, high-quality care. However, the company faces significant risks, including medical cost volatility, regulatory changes, and intense competition. It may suit growth-oriented investors with a high risk tolerance who are looking for exposure to healthcare reform, while those seeking stability or income should exercise caution.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers exposure to the value-based care shift but faces significant execution and margin risks. |
| Momentum investor | Weak fit | The stock has experienced high volatility, making it a challenging play for short-term momentum strategies. |
| Value investor | Weak fit | agilon health's history of negative earnings makes it a poor fit for traditional value metrics. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses on reinvesting capital for growth. |
| Low-risk investor | Weak fit | High operational leverage and market exposure make this a high-risk security. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is subject to significant swings based on sector-wide sentiments toward Medicare Advantage. |
| Valuation risk | Medium / high | Market valuations are highly sensitive to growth expectations and medical margin performance. |
| Competition risk | High | Intense competition from insurers and other clinical platforms threatens market share expansion. |
| Business quality | Medium | While the model is innovative, the company must prove long-term sustainable profitability. |
| Dividend income | Low / none | The company does not provide income to shareholders. |
| Execution risk | High | Successfully managing medical costs across disparate physician groups is operationally complex. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 277.82% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/15/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.55B USD | Price to earnings Ratio - | 1Y Target Price 115.08 |
Price to earnings Ratio - | 1Y Target Price 115.08 | ||
Volume (30-day avg) 295.9K shares | Beta 3.04 | 52 Weeks Range 7.48 - 133.04 | Updated Date 09/15/2026 |
52 Weeks Range 7.48 - 133.04 | Updated Date 09/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -15.23 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Physician Partner Services | Clinical support, data analytics, and shared savings arrangements. | The company earns money when its partner doctors reduce medical costs while maintaining quality care. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 178.57 | Enterprise Value 1.40B | Price to Sales(TTM) 0.26 |
Enterprise Value 1.40B | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 0.23 | Enterprise Value to EBITDA -104.52 | Shares Outstanding 16.79M | Shares Floating 10.93M |
Shares Outstanding 16.79M | Shares Floating 10.93M | ||
Percent Insiders 5.04 | Percent Institutions 96.47 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About agilon health Inc
Exchange NYSE | Headquarters Westerville, OH, United States | ||
IPO Launch date 2021-04-15 | CEO & Director Mr. Timothy Patrick O'Rourke | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 856 | Website https://www.agilonhealth.com |
Full time employees 856 | Website https://www.agilonhealth.com | ||
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.